Tardive dyskinesia and ethnicity: Review of the literature

Annals of Clinical Psychiatry

Volumn 9, Issue 1, 1997, Pages 53-59

  Swartz, J Randolph ^a,b   Burgoyne, Karl ^a,b   Smith, Michael ^a,b   Gadasally, Rangaswamy ^a,b   Ananth, Jambur ^a,b   Ananth, Kartik ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Biology of tardive dyskinesia; Ethnicity and tardive dyskinesia; Extrapyramidal signs; Genetics and tardive dyskinesia; Tardive dyskinesia

Indexed keywords

NEUROLEPTIC AGENT;

CEBIDAE; DEVELOPING COUNTRY; DISEASE CLASSIFICATION; ETHNIC DIFFERENCE; ETHNOLOGY; ETHNOPHARMACOLOGY; ETIOLOGY; FAMILY HISTORY; FEMALE; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; LONG TERM EXPOSURE; MACACA; MAJOR CLINICAL STUDY; MALE; MONKEY DISEASE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STRAIN DIFFERENCE; TARDIVE DYSKINESIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; ETHNIC GROUPS; FAMILY HEALTH; HUMANS; PREVALENCE;

EID: 0030854215     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026282325507     Document Type: Review

References (60)

1. Morgenstern H, Glazer WM, Niedzweicki D, Nourjah P: The impact of neuroleptic medication on tardive dyskinesia: A metaanalysis of published studies. Am J Public Health 1987; 77:717-724
2. Ananth J: Drug induced dyskinesia: A critical review. Int Pharmacopsychiatry 1979; 14:21-33
3. Roxburgh RA: Treatment of persistent phenothiazine induced oral dyskinesia. Br J Psychiatry 1970; 116:227-280
4. Jus A, Pineau R, Lachauce R: Epidemiology of tardive dyskinesia. Dis Nerv Syst 1976; 37:210-214
5. Casey DE, Hansen TE: Spontaneous dyskinesia. In: Jeste DV, Wyatt RJ, eds. Neuropsychiatric Movement Disorders. Washington, DC: America Psychiatric Press; 1984:68-95
6. Gerlach J, Casey DE: Tardive dyskinesia. Acta Psychiatr Scand 1988; 77:369-378
7. Werner MG, Kane JM, Lieverman JA, Alvir J, Bergmann KJ, Borenstein M, Schooler NR, Mukherjee S, Rotrosen J, Rubinstein M, Basavaraju N: The prevalence of tardive dyskinesia. J Clin Psychopharmacol 1991; 11(1):34-42
8. Yassa R, Ananth J: Familial tardive dyskinesia. Am J Psychiatry 1981; 138:1618-1619
9. Myrianthopoulos NC, Kurland AA, Kurland IT: Hereditary predisposition in drug induced parkinsonism. Arch Neurol 1962; 6:5-9
10. Myrianthopoulos NC, Waldrup FN, Vincent BL: A repeat study of hereditary predisposition to drug induced parkinsonism. Prog Neugenet 1967; 175:486-491
11. Ayd FJ Jr.: A survey of drug-induced extrapyramidal reactions. JAMA 1961; 175:1054
12. Rajput AH, Stern W, Christ A, Laverty W: Etiology of Parkinson's disease: Environmental factor(s). Neurology 1984; 34(1):207-214
13. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F: Brain dopamine and the syndromes of Parkinson and Hungtington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973; 20:415-455
14. Domino EF: Induction of tardive dyskinesia in cebus Apella and Macaca sepciosa monkeys: A review. In: Chase C, Gerlach C, eds. Dyskinesia: Research and Treatment. Springer-Verlag: Berlin, Heidelberg; 1985:217-223
15. Kane J, Struve F, Woerner M, Weinhold P: Preliminary findings with regards to risk factors in the development of tardive dyskinesia. Psychopharm Bull 1981; 17:47-49
16. Gureje O: Tardive dyskinesia in schizophrenics. Acta Psychiatr Scand 1987; 76:523-528
17. Yesavage JA, Bourgeois M, Kraemer H, Csernansky JG, Berger PA: Prevalence of tardive dyskinesia in 3140 French inpatients. J Nerv Men Dis 1982; 170:111-112
18. Altamura AC, Cavallaro R, Regazzetti MG: Prevalence and risk factors for tardive dyskinesia: A study in an Italian population of chronic schizophrenics. Eur Arch Psychiatry Clin Neurosci 1990; 240:9-12
19. Ko GN, Zhang LD, Yan WW, Zang MD, Buchner D, Xia ZY, Wyatt RJ, Jeste DV: The Shanghai 800: Prevalence of tardive dyskinesia in a Chinese psychiatric hospital. Am J Psychiatry 1989; 146:387-389
20. Chiu H, Shum P, Lau J, Lam L, Lee S: Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong. Am J Psychiatry 1992; 149:1081-1085
21. Pi EH, Kusuda M, Gray GE: Cross-cultural psychopharmacology: Neuroleptic-induced movements disorders. In: Keyzer H, ed. Phenothiazines and Structurally Related Compounds. Melbourne, FL: Krieger; 1992:399-408
22. Chiu H, Wing YK, Kwong PK, Leung CM, Lam LC: Prevalence of tardive dyskinesia in samples of elderly people in Hong Kong. Acta Psychiatr Scand 1993; 87:266-268
23. Kinoshita J, Inose T, Sakai H: Tardive dyskinesia - Studies on its clinical survey and postmortem examination of a case. Ann Rep Pharmacopsychiatry Res Found 1972; 4:221-229
24. Itoh H, Miura S, Yagi G, Ogita K: Irreversible dyskinesia due to the prolonged administration of psychotropics. Jap Med J 1973; 2582:29-34
25. Karasuyama N, Fujii K, Takahashi R: Tardive dyskinesia (abstract). Clin Neurol 1972; 12:687
26. Inada T, Ohnishi K, Kamisada M, Matsuda G, Tajima O, Yanagisawa Y, Hashiguchi K, Shima S, Oh-e Y, Masuda Y, Chiba T, Kamijima K, Rockhold RW, Yagi G: A prospective study of tardive dyskinesia in Japan. Eur Arch Psychiatry Clin Neurosci 1991; 240:250-254
27. Inada T, Yagi G, Kaijima K, Ohnishi K, Kamisada M, Rockhold RW: Clinical variants of tardive dyskinesia in Japan. Japan J Psychiatry Neurol 1991; 45(1):67-71
28. Koshino Y, Madokoro S, Ito T, Horie T, Mukai M, Isaki K: A survey of tardive dyskinesia in psychiatric inpatients in Japan. Clin Neuropharmacol 1992; 15(1):34-43
29. Gardos G, Samu I, Kallos M, Cole JO: Absence of severe tardive dyskinesia in Hungarian schizophrenic out-patients. Psychopharmacology 1980; 71:29-34
30. Muscettola G, Pampallona S, Barbato G, Casiello M, Bollini P: Tardive dyskinesia in Italy: Preliminary findings (letter). Arch Gen Psych 1989; 46(8):754-755
31. Kocher R, Fleischhauer J, Hobi V, Gilsdorf U: Dyskinesien in einer klinischen population. Schweizer Arch Neurol Neurochir Psychiatrie Band 1986; 137(2):63-78
32. Pandurangi AK, Channabasavanna HM, Ananth J: Dyskinesia in an Indian Mental Hospital. Indian J Psychiatry 1978; 20:339-342
33. Doongaji DR, Jeste DV, Jape NM, Sheth AS, Apte JS, Vahia VN, Desai AB, Vahora SA, Thatte S, Vevaina T, Bharadeway J: Tardive dyskinesia in India: a prevalence study. J Clin Psychopharmacol 1982; 2:341-344
34. Rittmannsberger H, Schony W: Pravalenz tardiver dyskinesie bei langzeit-hospitalisierten schizophrenen patienten. Nervenarzt 1986; 57:116-118
35. Schwartz M, Silver H, Tal I, Sharf B: Tardive dyskinesia in Northern Israel: Preliminary study. Eur Neurol 1993; 33:264-266
36. Ogita K, Yazi G, Itoh H, Miura S, Lambert PA: Comparative analysis of persistent dyskinesias of long-term usage with neuroleptics in France and Japan. Folia Psychiatry Neurol Japan 1975; 29:315-320
37. Binder RL, Kazamatsuri H, Nishimura T, McNiel DE: Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan. Am J Psychiatry 1987; 144:1494-1496
38. Pi, EH, Gutierrez MA, Gray GE: Tardive dyskinesia: Cross-cultural perspectives. In: Lin KM, Poland RE, Nakasaki G, eds. Psychopharmacology and Psychobiology of Ethnicity. Washington, DC: American Psychiatric Press; 1993:153-167
39. Sramek JJ, Roy S, Ahrens T, Pinanong P, Cutler N, Pi E: Prevalence of tardive dyskinesia among three ethnic groups of chronic psychiatric patients. Hosp Commun Psychiatry 1991; 42:590-592
40. Glazer WM, Morgenstern H, Doucette JT: Predicting the long term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. J Clin Psychiatry 1993; 54:133-139
41. Morgenstern H, Glazer WM: Identifying risk factors for tardive dyskinesia (TD) in the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry 1993; 50:723-733
42. Glazer WM, Morgenstern H, Doucette J: Race and tardive dyskinesia among outpatients at a CMHC. Hosp Commun Psychiatry 1994; 45:38-42
43. Tan CH, Tay LK: Tardive dyskinesia in elderly psychiatric patients in Singapore. Aust NZ J Psychiatry 1991; 25:119-122
44. Andrews HG: Clinical relationship of extrapyramidal symptoms and tardive dyskinesia. Can J Psychiatry 1994; 39 (Suppl 2):S77-S80
45. Barnes TRE: The clinical relationship between extrapyramidal symptoms and tardive dyskinesia. 9th World Congress of Psychiatry Abstracts; 1993: P1495
46. Casey DE: Tardive dyskinesia. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York: Raven Press; 1987:1411-1419
47. Binder RL, Levy R: Extrapyramidal reactions in Asians. Am J Psychiatry 1981; 138:1243-1244
48. Lin KM, Finder EJ: Neuroleptic dosage in Asians. Am J Psychiatry 1983; 140:490-491
49. Potkin SG, Shen Y, Pardes H: Haloperidol concentrations elevated in Chinese patients. Psychiatry Res 1984; 12:167-172
50. Rudorfer MV, Lane EA, Chang WH, Zhang M, Potter WZ: Desipramine pharmacokinetics in Chinese and Caucasian volunteers. Br J Clin Pharmacol 1984; 17:433-440
51. Kumana CR, Lauder IJ, Chan M, Ko W, Lin HJ: Differences in diazepam pharmacokinetics in Chinese and White Caucasians-relation to body lipid stores. Eur J Clin Pharmacol 1987; 32:211-215
52. Spector R, Choudhury AK, Chiang CK, Goldberg MJ, Ghoneim MM: Diphenhydramine in Orientals and Caucasians. Clin Pharmacol Ther 1980; 28:229-234
53. Zhou HH, Adedoyin A, Wilkinson GR: Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther 1990; 48:10-17
54. Lin KM, Poland RE, Nuccio I, Matsuda K, Hathuc N, Su TP, Fu P: A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients. Am J Psychiatry 1989; 146:1307-1311
55. Chang WH, Chen TY, Lee CF, Hu WH, Yeh EK: Low plasma reduced haloperidol/haloperidol ratios in Chinese patients. Biol Psychiatry 1987; 22:1406-1408
56. Ereshesfky L, Davis CM, Harrinton CA, Jann MW, Browning JL, Saklad SR, Burch NR: Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients. J Clin Psychopharmacol 1984; 4:138-142
57. Chang WH, Jahn MW, Hwu HG, Chen TY, Yeh EK, Chien CP, Ershelfsky L, Saklad SR, Richards AL: Ethnic comparison of haloperidol and reduced haloperidol plasma levels: Taiwan Chinese versus American non-Chinese. Clin Neuropsychopharmacol 1990; 13:538-539
58. Shostak M, Perel JM, Stiller RL, Wyman W, Curran S: Plasma haloperidol and clinical response: A role for reduced haloperidol in antipsychotic activity? J Clin Psychopharmacol 1987; 7:394-400
59. Altamura AC, Mauri M, Cavallaro R, Colacurio F, Gorni A, Boreggi S: Reduced haloperidol/haloperidol ratio and clinical outcome in schizophrenia: Preliminary evidence. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12:689-694
60. Ko GN, Korpi ER, Kirsh DG: Haloperidol/reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients. J Clin Pharmacol 1989; 9:186-190